To compare the safety and durability of a single intravesical trigonal-only versus 20 trigone-sparing injections of OnabotulinumtoxinA (BTA) for refractory OAB.
A chart review of all idiopathic OAB patients treated with BTA from January 2016 to December 2018 was performed.